These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10833780)

  • 1. Pathogenic effects of a high peritoneal transport rate.
    Heaf J
    Semin Dial; 2000; 13(3):188-93. PubMed ID: 10833780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time dependence of solute removal during a single exchange.
    Wang T; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Adv Perit Dial; 1997; 13():23-8. PubMed ID: 9360645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG; Holmes DL; Dennis RL
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to improve clinical outcomes in peritoneal dialysis patients: delivered dose and membrane transport.
    Churchill DN
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S58-62. PubMed ID: 9892367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
    Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
    Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
    Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine Software.
    Hodzic E; Rasic S; Klein C; Covic A; Unsal A; Cunquero JM; Prischl FC; Gauly A; Kalicki RM; Uehlinger DE
    Artif Organs; 2016 Feb; 40(2):144-52. PubMed ID: 26147618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
    Tzamaloukas AH; Malhotra D; Murata GH
    ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
    Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
    Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The problem of the high transporter: is survival decreased?
    Correa-Rotter R; Cueto-Manzano A
    Perit Dial Int; 2001; 21 Suppl 3():S75-9. PubMed ID: 11887868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
    Nakamoto H; Imai H; Kawanishi H; Nakamoto M; Minakuchi J; Kumon S; Watanabe S; Shiohira Y; Ishii T; Kawahara T; Suzuki H
    Adv Perit Dial; 2001; 17():238-43. PubMed ID: 11510284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
    Tinroongroj N; Jittikanont S; Lumlertgul D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.